TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to
release third quarter 2015 financial and operating results before the
market opens on Thursday, November 5, 2015. Todd M. Pope, President &
Chief Executive Officer and Joseph P. Slattery, Executive Vice President
and Chief Financial Officer will host a conference call to discuss these
results starting at 8:30 am Eastern Time the same day. The call will be
concurrently webcast.
To listen to the conference call on your telephone, please dial,
888-417-8465 for domestic callers and 719-325-2494 for
international callers, and reference TransEnterix Call approximately ten
minutes prior to the start time. To access the live audio webcast or
archived recording, use the following link http://ir.transenterix.com/events.cfm.
The replay will be available on the Company’s website.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of
robotics to improve minimally invasive surgery by addressing the
clinical and economic challenges associated with current laparoscopic
and robotic options. The company is focused on the development and
commercialization of the SurgiBot™ System, a single-port, robotically
enhanced laparoscopic surgical platform, and the commercialization of
ALF-X®, a multi-port robotic system that brings the advantages of
robotic surgery to patients while enabling surgeons with innovative
technology such as haptic feedback and eye tracking camera control. The
SurgiBot System is not yet available for sale in any market. The ALF-X
has been granted a CE Mark but is not available for sale in the US. For
more information, visit the TransEnterix website at www.transenterix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151027006719/en/
Copyright Business Wire 2015